Chronic Venous Occlusions Treatment Market worth USD 9.5 billion by 2030, says Global Market Insights Inc.
Chronic venous occlusions treatment industry is anticipated to register 5.5% CAGR between 2022 and 2030 due to rise in the number of orthopedic procedures & growing preference for minimally invasive procedures
Selbyville, Delaware, Nov. 23, 2022 (GLOBE NEWSWIRE) —
Chronic venous occlusions treatment
Growing acceptance of advanced technological devices at hospitals to expand segmental share
Chronic venous occlusions treatment market from hospitals segment was valued at over USD 3.5 billion in 2021. The rapid adoption of technologically improved venous occlusion devices, coupled with the availability of minimally invasive treatment alternatives for numerous lower extremity disorders to aid a large client base, is mainly responsible for segment growth. Rising patient admissions with chronic venous diseases, improved access to better care and diagnostics, and the presence of experienced healthcare personnel will increase patient visits to hospitals, escalating the overall segment revenues.
Increasing hospitalization rate to amplify Europe’s revenue share
Europe chronic venous occlusions treatment market is expected to be worth over USD 2.5 billion by 2030 driven by the rising hospitalization rate brought on by the high frequency of venous leg ulcers, lower extremity disorders, chronic venous insufficiency, and supporting healthcare policies. Additionally, several screening programs and awareness campaigns implemented by the regulatory authorities are primed to complement business expansion.
Request for customization of this research report @ https://www.gminsights.com/roc/5398
Product innovations to define the market outlook
Stryker Corporation, Sanofi, Medtronic plc, Sigvaris AG, Pfizer Inc., Medi GmbH & Co. KG, Tactile Medical, Julius Zorn GmbH, Bristol Myers Squibb, Smith & Nephew PLC, Viatris Inc., Boston Scientific Corporation, Merz Pharma, Lumenis Ltd., Candela, Bayer AG, Sciton, Inc, Fotona, ConvaTec Inc., Leucadia Pharmaceuticals (Hikma), 3M Company, and Venclose, Inc. (Becton Dickinson and Company) and others are some major medical and healthcare technology companies operating in the market.
Browse Our Reports Store – GMIPulse @ https://www.gminsights.com/gmipulse
About Global Market Insights
Global Market Insights Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.
CONTACT: Contact Us: Aashit Tiwari Corporate Sales, USA Global Market Insights Inc. Toll Free: +1-888-689-0688 USA: +1-302-846-7766 Europe: +44-742-759-8484 APAC: +65-3129-7718 Email: [email protected] Read More News @ https://ibmag.com
